LTR Pharma Limited
LTPLF
$0.27
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -783.60K | -805.70K | -1.46M | -1.45M | -826.90K |
| Total Depreciation and Amortization | 300.00 | 300.00 | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.60K | 3.70K | 324.60K | 324.00K | 108.40K |
| Change in Net Operating Assets | -- | -- | 179.30K | 178.90K | -- |
| Cash from Operations | -779.70K | -801.70K | -951.40K | -949.40K | -718.50K |
| Capital Expenditure | -2.80K | -2.90K | -700.00 | -700.00 | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.80K | -2.90K | -700.00 | -700.00 | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.75M | 17.75M | 0.00 | 0.00 | 3.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.07M | -1.07M | 0.00 | 0.00 | -252.00K |
| Cash from Financing | 10.87M | 11.18M | 0.00 | 0.00 | 2.12M |
| Foreign Exchange rate Adjustments | -- | -- | -9.20K | -9.20K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.09M | 10.38M | -961.20K | -959.30K | 1.40M |